Nakagawa Masahiro

Affiliation and department：

Research field (1)： Tumor biology

Research theme for competitive and other funds (7)：

2022 - 2026 Investigation of development mechanism and preemptive medicine for IDH-mutant glioma based on genomic analysis of normal brain tissues
2022 - 2025 マルチオミクス単一細胞解析を用いた白血病進展機構の解明
2019 - 2024 comprehensive studies on the molecular basis of early development and clonal evolution in cancer using advanced genomics.
2017 - 2020 Analysis of residual disease using newly developed single cell RNA sequencing.
2008 - 2009 Functional analysis of AML1-target genes in hematological malignancy.

Show all

Papers (103)：

中川正宏, 稲垣良作, 黒田隆, 南谷泰仁, 趙蘭英, 越智陽太郎, 本村公則, 竹田淳恵, 戚星星, 岡崎幸治, et al. 単一細胞マルチオミクス解析によるクローン造血の病態解明. 日本血液学会学術集会. 2023. 85回. 287-287
越智陽太郎, 南谷泰仁, Liew-Littorin Markus, 笠原千嗣, 平本展大, 兼村信宏, 瀬崎伸夫, 櫻田麻希, 岩崎惇, 諫田淳也, et al. クロマチンアクセシビリティ解析による急性骨髄性白血病のエピジェネティクス不均一性の解明. 日本血液学会学術集会. 2023. 85回. 1459-1459
Mayuki Omatsu, Yuki Nakanishi, Kosuke Iwane, Naoki Aoyama, Angeles Duran, Yu Muta, Anxo Martinez-Ordoñez, Qixiu Han, Nobukazu Agatsuma, Kenta Mizukoshi, et al. THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer. Nature communications. 2023. 14. 1. 5534-5534
依田成玄, 森下大輔, 越智陽太郎, 水谷明生, 森拓人, 竹田淳恵, 戸崎浩和, 佐藤義彦, 牧島秀樹, 中川正宏, et al. がんのRNA異常の核心に迫る/The Nexus of RNA Dysregulation in Cancer 骨髄性腫瘍を標的とした新規スプライシング阻害剤CTX-712の開発(CTX-712, a novel splicing inhibitor targeting myeloid neoplasms). 日本癌学会総会記事. 2023. 82回. 737-737
昆彩奈, 中川正宏, 片岡圭亮, 森拓人, 垣内伸之, 牧島秀樹, 越智陽太郎, 中山学, 古関明彦, 南谷泰仁, et al. 骨髄系腫瘍におけるDDX41胚細胞変異・体細胞変異の分子病態の解明(Pathogenetic role of germline and somatic DDX41 mutations in the pathogenesis of myeloid malignancies). 日本癌学会総会記事. 2023. 82回. 1686-1686

ｍore...

MISC (51)：

June Takeda, Kenichi Yoshida, Masahiro M. Nakagawa, Yasuhito Nannya, Akinori Yoda, Ryunosuke Saiki, Yotaro Ochi, Lanying Zhao, Rurika Okuda, Xingxing Qi, et al. Amplified EPOR/JAK2 genes definea unique subtype of acute erythroid leukemia. CANCER RESEARCH. 2022. 82. 12
June Takeda, Kenichi Yoshida, Masahiro Marshall Nakagawa, Yasuhito Nannya, Akinori Yoda, Daisuke Morishita, Ryunosuke Saiki, Kenichi Chiba, Hiroko Tanaka, Yuichi Shiraishi, et al. EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia. BLOOD. 2021. 138
Ayana Kon, Masahiro Nakagawa, Ryosaku Inagaki, Keisuke Kataoka, Yotaro Ochi, Hideki Makishima, Manabu Nakayama, Haruhiko Koseki, Yasuhito Nannya, Seishi Ogawa. The functional role of compound DDX41 germline and somatic R525H mutations in the development of myeloid neoplasms. CANCER SCIENCE. 2021. 112. 454-454
Masahiro Nakagawa, Ryosaku Inagaki, Yasuhito Nannya, Lanying Zhao, Yotaro Ochi, June Takeda, Xingxing Qi, Akinori Yoda, Ayana Kon, Nobuyuki Kakiuchi, et al. Early Clonal evolution of myeloid malignancies. CANCER SCIENCE. 2021. 112. 969-969
June Takeda, Kenichi Yoshida, Akinori Yoda, Yasuhito Nannya, Masahiro Nakagawa, Yotaro Ochi, Ayana Kon, Tetsuichi Yoshizato, Yusuke Shiozawa, Yuichi Shiraishi, et al. JAK STAT Pathway is a Promising Therapeutic target in Acute Erythroid Leukemia. CANCER SCIENCE. 2021. 112. 453-453

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page